ID ANFC_HUMAN Reviewed; 126 AA. AC P23582; Q4ZG41; DT 01-NOV-1991, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1991, sequence version 1. DT 27-MAR-2024, entry version 191. DE RecName: Full=C-type natriuretic peptide; DE Contains: DE RecName: Full=CNP-22; DE Contains: DE RecName: Full=CNP-29; DE Contains: DE RecName: Full=CNP-53; DE Flags: Precursor; GN Name=NPPC; Synonyms=CNP2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=2018508; DOI=10.1016/0006-291x(91)91614-i; RA Tawaragi Y., Fuchimura K., Tanaka S., Minamino N., Kangawa K., Matsuo H.; RT "Gene and precursor structures of human C-type natriuretic peptide."; RL Biochem. Biophys. Res. Commun. 175:645-651(1991). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=1339402; DOI=10.1161/01.hyp.19.6.809; RA Ogawa Y., Nakao K., Nakagawa O., Komatsu Y., Hosoda K., Suga S., Arai H., RA Nagata K., Yoshida N., Imura H.; RT "Human C-type natriuretic peptide. Characterization of the gene and RT peptide."; RL Hypertension 19:809-813(1992). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP PROTEIN SEQUENCE OF 98-126. RX PubMed=1472040; DOI=10.1016/0006-291x(92)92257-x; RA Ishizaka Y., Kangawa K., Minamino N., Ishii K., Takano S., Eto T., RA Matsuo H.; RT "Isolation and identification of C-type natriuretic peptide in human RT monocytic cell line, THP-1."; RL Biochem. Biophys. Res. Commun. 189:697-704(1992). RN [6] RP FUNCTION (CNP-22). RX PubMed=1672777; DOI=10.1126/science.1672777; RA Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K., Matsuo H., RA Goeddel D.V.; RT "Selective activation of the B natriuretic peptide receptor by C-type RT natriuretic peptide (CNP)."; RL Science 252:120-123(1991). RN [7] RP TISSUE SPECIFICITY (CNP-22). RX PubMed=9794555; DOI=10.1093/ndt/13.10.2529; RA Herten M., Lenz W., Gerzer R., Drummer C.; RT "The renal natriuretic peptide urodilatin is present in human kidney."; RL Nephrol. Dial. Transplant. 13:2529-2535(1998). RN [8] RP FUNCTION (CNP-22), AND PROTEOLYTIC DEGRADATION BY IDE (CNP-22). RX PubMed=21098034; DOI=10.1074/jbc.m110.173252; RA Ralat L.A., Guo Q., Ren M., Funke T., Dickey D.M., Potter L.R., Tang W.J.; RT "Insulin-degrading enzyme modulates the natriuretic peptide-mediated RT signaling response."; RL J. Biol. Chem. 286:4670-4679(2011). RN [9] RP PHARMACEUTICAL, AND REVIEW. RX PubMed=29941213; DOI=10.1016/j.ijcard.2018.06.002; RA Ichiki T., Dzhoyashvili N., Burnett J.C. Jr.; RT "Natriuretic peptide based therapeutics for heart failure: cenderitide: a RT novel first-in-class designer natriuretic peptide."; RL Int. J. Cardiol. 281:166-171(2019). RN [10] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 105-126 IN COMPLEX WITH NPR3, AND RP DISULFIDE BOND. RX PubMed=11533490; DOI=10.1126/science.1062246; RA He X.-L., Chow D.-C., Martick M.M., Garcia K.C.; RT "Allosteric activation of a spring-loaded natriuretic peptide receptor RT dimer by hormone."; RL Science 293:1657-1662(2001). CC -!- FUNCTION: [CNP-22]: Hormone which plays a role in endochondral CC ossification through regulation of cartilaginous growth plate CC chondrocytes proliferation and differentiation (By similarity). May CC also be vasoactive and natriuretic (PubMed:1672777). Acts by CC specifically binding and stimulating NPR2 to produce cGMP CC (PubMed:1672777, PubMed:21098034). Binds the clearance receptor NPR3 CC (PubMed:11533490). {ECO:0000250|UniProtKB:Q61839, CC ECO:0000269|PubMed:11533490, ECO:0000269|PubMed:1672777, CC ECO:0000269|PubMed:21098034}. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: [CNP-22]: In the kidney, predominantly expressed in CC the distal tubular cells (at protein level). CC {ECO:0000269|PubMed:9794555}. CC -!- PTM: [CNP-22]: Degraded by IDE (in vitro). CC {ECO:0000269|PubMed:21098034}. CC -!- PHARMACEUTICAL: Cenderitide, a chimeric peptide consisting of C-type CC natriuretic peptide (NPPC) fused to the C-terminal tail of Dendroaspis CC natriuretic peptide (DNP) is under phase II clinical trial to treat CC heart failure (HF) with reduced ejection fraction (HFrEF) and HF with CC preserved ejection fraction (HFpEF). unlike the 2 peptides from which CC it is derived, Cenderitide activates both NPR1 and NPR2. CC {ECO:0000305|PubMed:29941213}. CC -!- SIMILARITY: Belongs to the natriuretic peptide family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M64710; AAA35703.1; -; Genomic_DNA. DR EMBL; D90337; BAA14351.1; -; Genomic_DNA. DR EMBL; AC013435; AAX88912.1; -; Genomic_DNA. DR EMBL; BC069120; AAH69120.1; -; mRNA. DR EMBL; BC105065; AAI05066.1; -; mRNA. DR EMBL; BC105067; AAI05068.1; -; mRNA. DR CCDS; CCDS2489.1; -. DR PIR; JT0567; AWHUC. DR RefSeq; NP_077720.1; NM_024409.3. DR RefSeq; XP_011509547.1; XM_011511245.2. DR PDB; 1JDP; X-ray; 2.00 A; H=105-126. DR PDBsum; 1JDP; -. DR AlphaFoldDB; P23582; -. DR SMR; P23582; -. DR BioGRID; 110940; 10. DR STRING; 9606.ENSP00000387159; -. DR TCDB; 1.C.46.1.1; the c-type natriuretic peptide (cnp) family. DR GlyGen; P23582; 2 sites, 1 O-linked glycan (2 sites). DR iPTMnet; P23582; -. DR PhosphoSitePlus; P23582; -. DR BioMuta; NPPC; -. DR DMDM; 113850; -. DR jPOST; P23582; -. DR MassIVE; P23582; -. DR PaxDb; 9606-ENSP00000387159; -. DR PeptideAtlas; P23582; -. DR ProteomicsDB; 54134; -. DR Antibodypedia; 50954; 313 antibodies from 31 providers. DR DNASU; 4880; -. DR Ensembl; ENST00000295440.2; ENSP00000295440.2; ENSG00000163273.4. DR Ensembl; ENST00000409852.2; ENSP00000387159.1; ENSG00000163273.4. DR GeneID; 4880; -. DR KEGG; hsa:4880; -. DR MANE-Select; ENST00000409852.2; ENSP00000387159.1; NM_024409.4; NP_077720.1. DR UCSC; uc002vsl.3; human. DR AGR; HGNC:7941; -. DR CTD; 4880; -. DR DisGeNET; 4880; -. DR GeneCards; NPPC; -. DR HGNC; HGNC:7941; NPPC. DR HPA; ENSG00000163273; Tissue enhanced (brain). DR MIM; 600296; gene. DR neXtProt; NX_P23582; -. DR OpenTargets; ENSG00000163273; -. DR PharmGKB; PA31735; -. DR VEuPathDB; HostDB:ENSG00000163273; -. DR eggNOG; ENOG502S2QY; Eukaryota. DR GeneTree; ENSGT00390000015492; -. DR HOGENOM; CLU_160791_0_0_1; -. DR InParanoid; P23582; -. DR OMA; HDYPNAR; -. DR OrthoDB; 4269066at2759; -. DR PhylomeDB; P23582; -. DR TreeFam; TF106305; -. DR PathwayCommons; P23582; -. DR Reactome; R-HSA-5578768; Physiological factors. DR SignaLink; P23582; -. DR SIGNOR; P23582; -. DR BioGRID-ORCS; 4880; 11 hits in 1134 CRISPR screens. DR EvolutionaryTrace; P23582; -. DR GenomeRNAi; 4880; -. DR Pharos; P23582; Tbio. DR PRO; PR:P23582; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; P23582; Protein. DR Bgee; ENSG00000163273; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 85 other cell types or tissues. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; IEA:Ensembl. DR GO; GO:0032991; C:protein-containing complex; IDA:CAFA. DR GO; GO:0030141; C:secretory granule; IEA:Ensembl. DR GO; GO:0005179; F:hormone activity; IBA:GO_Central. DR GO; GO:0051427; F:hormone receptor binding; IPI:UniProtKB. DR GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB. DR GO; GO:0001525; P:angiogenesis; IEA:Ensembl. DR GO; GO:0097746; P:blood vessel diameter maintenance; IEA:UniProtKB-KW. DR GO; GO:0001974; P:blood vessel remodeling; IEA:Ensembl. DR GO; GO:0061939; P:c-di-GMP signaling; IEA:Ensembl. DR GO; GO:1904588; P:cellular response to glycoprotein; IEA:Ensembl. DR GO; GO:0006182; P:cGMP biosynthetic process; IDA:GO_Central. DR GO; GO:0019934; P:cGMP-mediated signaling; IEA:Ensembl. DR GO; GO:0051276; P:chromosome organization; IEA:Ensembl. DR GO; GO:0001549; P:cumulus cell differentiation; IEA:Ensembl. DR GO; GO:0035483; P:gastric emptying; IEA:Ensembl. DR GO; GO:0003418; P:growth plate cartilage chondrocyte differentiation; ISS:UniProtKB. DR GO; GO:0003419; P:growth plate cartilage chondrocyte proliferation; ISS:UniProtKB. DR GO; GO:0006874; P:intracellular calcium ion homeostasis; IEA:Ensembl. DR GO; GO:1903537; P:meiotic cell cycle process involved in oocyte maturation; IEA:Ensembl. DR GO; GO:0071965; P:multicellular organismal locomotion; IEA:Ensembl. DR GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl. DR GO; GO:0032966; P:negative regulation of collagen biosynthetic process; IEA:Ensembl. DR GO; GO:2000279; P:negative regulation of DNA biosynthetic process; IEA:Ensembl. DR GO; GO:0051447; P:negative regulation of meiotic cell cycle; IDA:MGI. DR GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl. DR GO; GO:1900194; P:negative regulation of oocyte maturation; IDA:MGI. DR GO; GO:0001503; P:ossification; IEA:UniProtKB-KW. DR GO; GO:0010753; P:positive regulation of cGMP-mediated signaling; IEA:Ensembl. DR GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl. DR GO; GO:0009791; P:post-embryonic development; IEA:Ensembl. DR GO; GO:0006457; P:protein folding; IDA:CAFA. DR GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:UniProtKB. DR GO; GO:0040014; P:regulation of multicellular organism growth; IEA:Ensembl. DR GO; GO:0048660; P:regulation of smooth muscle cell proliferation; IEA:Ensembl. DR GO; GO:0048678; P:response to axon injury; IEA:Ensembl. DR GO; GO:0045471; P:response to ethanol; IEA:Ensembl. DR GO; GO:0001666; P:response to hypoxia; IEA:Ensembl. DR GO; GO:0002931; P:response to ischemia; IEA:Ensembl. DR GO; GO:0090649; P:response to oxygen-glucose deprivation; IEA:Ensembl. DR GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl. DR InterPro; IPR002406; C_natriurtcpep. DR InterPro; IPR000663; Natr_peptide. DR InterPro; IPR030480; Natr_peptide_CS. DR PANTHER; PTHR12167; C-TYPE NATRIURETIC PEPTIDE; 1. DR PANTHER; PTHR12167:SF2; C-TYPE NATRIURETIC PEPTIDE; 1. DR Pfam; PF00212; ANP; 1. DR PRINTS; PR00713; CNATPEPTIDE. DR PRINTS; PR00710; NATPEPTIDES. DR SMART; SM00183; NAT_PEP; 1. DR PROSITE; PS00263; NATRIURETIC_PEPTIDE; 1. DR Genevisible; P23582; HS. PE 1: Evidence at protein level; KW 3D-structure; Cleavage on pair of basic residues; KW Direct protein sequencing; Disulfide bond; Hormone; Osteogenesis; KW Pharmaceutical; Reference proteome; Secreted; Signal; Vasoactive. FT SIGNAL 1..23 FT /evidence="ECO:0000255" FT PROPEP 24..73 FT /id="PRO_0000001553" FT PEPTIDE 74..126 FT /note="CNP-53" FT /id="PRO_0000001554" FT PEPTIDE 98..126 FT /note="CNP-29" FT /evidence="ECO:0000269|PubMed:1472040" FT /id="PRO_0000001555" FT PEPTIDE 105..126 FT /note="CNP-22" FT /id="PRO_0000001556" FT REGION 20..71 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT DISULFID 110..126 FT /evidence="ECO:0000269|PubMed:11533490" FT VARIANT 82 FT /note="R -> Q (in dbSNP:rs5267)" FT /id="VAR_014583" SQ SEQUENCE 126 AA; 13246 MW; 58F6E657868F9A2D CRC64; MHLSQLLACA LLLTLLSLRP SEAKPGAPPK VPRTPPAEEL AEPQAAGGGQ KKGDKAPGGG GANLKGDRSR LLRDLRVDTK SRAAWARLLQ EHPNARKYKG ANKKGLSKGC FGLKLDRIGS MSGLGC //